Habibzadeh Mohammadreza, Ghosouri Atefeh, Vazifeh Azadani Zahra, Farajzadegan Ziba
Department of Anesthesiology, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Community and Family Medicine, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2025 Aug 26;14:94. doi: 10.4103/abr.abr_150_24. eCollection 2025.
This study aimed to evaluate the effects of different doses of dexmedetomidine and propofol on sedation, hemodynamic changes, and postoperative complications in patients undergoing ovarian puncture surgery.
This randomized controlled trial was conducted on 96 women candidates for ovarian puncture surgery. In the first group (DEX-0.5), a bolus dose of dexmedetomidine 0.5 µg/kg was administered for the induction of anesthesia, followed by a maintenance dose of dexmedetomidine 0.5 µg/kg/min. In the second group (DEX-1), a bolus dose of dexmedetomidine 1 µg/kg was administered for induction, followed by a maintenance dose of dexmedetomidine 1 µg/kg/min. In the third group (control group), propofol 50 µg/kg/min was administered for induction of anesthesia.
SBP, DBP, and MAP were significantly lower in the control group compared to the other groups ( value < 0.05). The mean scores of patient and surgical satisfaction levels in the DEX-0.5 group were significantly higher than the control group (4.00 ± 1.02 and 4.41 ± 0.57, respectively) and in the DEX-1 group (6.00 ± 1.35 and 4.61 ± 0.56, respectively) compared to the control group (2.90 ± 2.10 and 3.10 ± 0.32, respectively) ( value < 0.05). Need for additional analgesics was significantly higher in the control group compared to the intervention groups ( value < 0.05).
It seems that the administration of dexmedetomidine 1 µg/kg, due to better pain relief, higher satisfaction, less need for additional analgesics, and minimal occurrence of complications, can be recommended as a safe and effective dose in ovarian puncture surgery.
本研究旨在评估不同剂量右美托咪定和丙泊酚对接受卵巢穿刺手术患者的镇静效果、血流动力学变化及术后并发症的影响。
本随机对照试验对96名卵巢穿刺手术候选女性进行。第一组(DEX - 0.5),给予负荷剂量右美托咪定0.5μg/kg诱导麻醉,随后以0.5μg/kg/min的维持剂量给药。第二组(DEX - 1),给予负荷剂量右美托咪定1μg/kg诱导麻醉,随后以1μg/kg/min的维持剂量给药。第三组(对照组),给予丙泊酚50μg/kg/min诱导麻醉。
与其他组相比,对照组的收缩压、舒张压和平均动脉压显著更低(P值<0.05)。DEX - 0.5组患者和手术满意度的平均得分显著高于对照组(分别为4.00±1.02和4.41±0.57),DEX - 1组与对照组相比也显著更高(分别为6.00±1.35和4.61±0.56),而对照组分别为2.90±2.10和3.10±0.32(P值<0.05)。与干预组相比,对照组对额外镇痛药的需求显著更高(P值<0.05)。
似乎给予1μg/kg右美托咪定,由于更好的镇痛效果、更高的满意度、更少的额外镇痛药需求以及最少的并发症发生,可被推荐为卵巢穿刺手术中安全有效的剂量。